|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
ELV033120358 |
003 |
DE-627 |
005 |
20230623224647.0 |
007 |
cr uuu---uuuuu |
008 |
180603s2013 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1016/S0378-3782(13)70012-4
|2 doi
|
028 |
5 |
2 |
|a GBVA2013012000013.pica
|
035 |
|
|
|a (DE-627)ELV033120358
|
035 |
|
|
|a (ELSEVIER)S0378-3782(13)70012-4
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
082 |
0 |
|
|a 610
|
082 |
0 |
4 |
|a 610
|q DE-600
|
082 |
0 |
4 |
|a 618.3/005
|q OCLC
|
082 |
0 |
4 |
|a 610
|q VZ
|
082 |
0 |
4 |
|a 610
|q VZ
|
084 |
|
|
|a 44.45
|2 bkl
|
100 |
1 |
|
|a Bont, Louis
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Viral respiratory burden in moderate-to-late preterm infants
|
264 |
|
1 |
|c 2013
|
300 |
|
|
|a 3
|
336 |
|
|
|a nicht spezifiziert
|b zzz
|2 rdacontent
|
337 |
|
|
|a nicht spezifiziert
|b z
|2 rdamedia
|
338 |
|
|
|a nicht spezifiziert
|b zu
|2 rdacarrier
|
520 |
|
|
|a More than 1 in 10 babies are born prematurely and most of them are born after gestational age 32 weeks. Mortality and morbidity are more common in these moderate-to-late preterm infants than in full-term children. In this review, mechanisms and epidemiology of long-term airway morbidity in moderate-to-late preterm infants will be discussed. We discuss the potential of viral respiratory infections to further aggravate abnormal lung function associated with preterm birth.
|
650 |
|
7 |
|a Lung function
|2 Elsevier
|
650 |
|
7 |
|a Respiratory syncytial virus
|2 Elsevier
|
650 |
|
7 |
|a Prematurity
|2 Elsevier
|
650 |
|
7 |
|a Bronchiolitis
|2 Elsevier
|
700 |
1 |
|
|a Blanken, Maarten
|4 oth
|
773 |
0 |
8 |
|i Enthalten in
|n Elsevier Science
|a Abdel-Aziz, Tarek Ezzat ELSEVIER
|t Study of serum leptin in well differentiated thyroid carcinoma: Correlation with patient and tumor characteristics
|d 2014
|g Amsterdam [u.a.]
|w (DE-627)ELV022803173
|
773 |
1 |
8 |
|g volume:89
|g year:2013
|g pages:37-39
|g extent:3
|
856 |
4 |
0 |
|u https://doi.org/10.1016/S0378-3782(13)70012-4
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_U
|
912 |
|
|
|a GBV_ELV
|
912 |
|
|
|a SYSFLAG_U
|
912 |
|
|
|a SSG-OLC-PHA
|
912 |
|
|
|a GBV_ILN_130
|
912 |
|
|
|a GBV_ILN_350
|
936 |
b |
k |
|a 44.45
|j Immunologie
|q VZ
|
951 |
|
|
|a AR
|
952 |
|
|
|d 89
|j 2013
|h 37-39
|g 3
|y 89.2013, S37-, (3 S.)
|
953 |
|
|
|2 045F
|a 610
|